NC TREK 1012449-25Recalls & reported problems
Abbott Vascular Inc. · NC TREK Coronary Dilatation Catheter 3.0 mm x 25 mm / Rapid-Exchange · Class 2
All models of NC TREK (56)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08717648151897), received between Feb 24, 2017 and Dec 13, 2019 — classified as 1 injury, 3 malfunctions.
The most frequently reported specific device problem is “Detachment Of Device Component” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Detachment Of Device Component2
- Difficult to Remove1
- Failure to Advance1
- Improper or Incorrect Procedure or Method1
- Material Rupture1
- Material Separation1
Patient problems
- No Patient Involvement2
- Foreign Body In Patient1
- No Consequences Or Impact To Patient1
- Vessel Or Plaque, Device Embedded In1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryDec 13, 2019Difficult to Remove; Material Separation; Difficult to Remove; Material Separation
SUBSEQUENT TO THE INITIALLY FILED REPORT, THE FOLLOWING INFORMATION WAS RECEIVED: THERE WAS RESISTANCE DURING REMOVAL OF THE 3.0 X 25 MM NC TREK BALLOON DILATION CATHETER (BDC) DUE TO THE ANATOMY WHEN THE DISTAL END OF THE BDC BECAME DETACHED. AN UNSPECIFED STENT WAS DEPLOYED TO EMBED THE DETACHED PORTION OF THE BDC. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Foreign Body In Patient; Vessel Or Plaque, Device Embedded In
MAUDE report 9465741 ↗MalfunctionJul 25, 2019Material Rupture; Improper or Incorrect Procedure or Method; Material Rupture; Improper or Incorrect Procedure or Method
IT WAS REPORTED THAT DURING PREPARATION AND BEFORE USE, THE NC TREK RX BALLOON WAS OVER-INFLATED AND RUPTURED OUTSIDE THE PATIENT. THE DEVICE WAS NOT USED AND THERE WAS NO PATIENT INVOLVEMENT. THERE WAS NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. ANOTHER NC TREK RX WAS USED TO COMPLETE THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Patient Involvement
MAUDE report 8827798 ↗MalfunctionFeb 22, 2018Detachment Of Device Component
IT WAS REPORTED THAT A 3.0 X 25MM NC TREK BALLOON DILATATION CATHETER WAS PREPPED ACCORDINGLY, HOWEVER, AFTER PREP IT WAS NOTED THAT THE PROXIMAL (SHAFT) WAS BROKEN INTO TWO PIECES AT ABOUT 10 CM. THE DEVICE WAS NOT USED ON THE PATIENT. ANOTHER SAME SIZE NC TREK WAS USED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE AND NO ADVERSE PATIENT EFFECTS. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Patient Involvement
MAUDE report 7290844 ↗MalfunctionFeb 24, 2017Detachment Of Device Component; Failure to Advance
IT WAS REPORTED THAT THE 3.0X25 NC TREK WAS BEING ADVANCED AROUND A BEND IN THE HEAVILY CALCIFIED, HEAVILY TORTUOUS DIAGONAL CORONARY ARTERY FOR POST DILATATION OF A XIENCE WHEN THE MIDDLE OF THE SHAFT SEPARATED. THE SEPARATED SHAFT WAS REMOVED MANUALLY AND ANOTHER NC TREK WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6358642 ↗
Other Catheters, transluminal coronary angioplasty, percutaneous devices
- MINI TREK™ 1012270-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous223 reports
- Maverick²™ H7493892815200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous1 death203 reports
- MINI TREK™ 1012270-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous162 reports
- Maverick²™ H7493892820200Boston Scientific Corporation · Catheters, transluminal coronary angioplasty, percutaneous161 reports
- NC TREK 1012454-08Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 recalls59 reports
- TREK™ 1012272-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous2 deaths158 reports
- NC TREK 1012453-12Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall84 reports
- NC TREK 1012453-15Abbott Vascular Inc. · Catheters, transluminal coronary angioplasty, percutaneous1 recall1 death83 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page